India's pharmaceutical industry is a global leader in volume, producing 60% of the world's medicines, but captures only 6% of its value. The strategic challenge is to transition from generics to high-value biologics and innovation to achieve a $350 billion export target by 2047, highlighting a critical policy-entrepreneurship partnership.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Global Pharma Volume Share: 60%
- ›Global Pharma Value Share: 6%
- ›Target this Data: 60% (global volume) vs 6% (global value) share of Indian pharma.
- ›Target this Nodal Body: The policymakers behind the Indian Patents Act, 1970 (e.g., Justice Rajagopala Ayyangar).
- ›Target this Legal Point: The Indian Patents Act, 1970 and the US Hatch-Waxman Act, 1984.
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.